ApertoConsorzio / Partenariato

Clinical trials for advancing innovative interventions for neurodegenerative diseases

Ente erogante: Commissione Europea - Horizon Europe

Scadenza

13 aprile 2027

361 giorni rimanenti

Forma

Non specificata

Budget totale

Non specificato

Contributo max

Non specificato

Descrizione del bando

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The scientific and clinical communities make effective use of state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to underpin and complement the development of innovative interventions aimed at more effective treatments for neurodegenerative diseases.The scientific and clinical communities benefit from the exchange of data, knowledge and best practices, thereby strengthening their collaboration in the EU, the Associated Countries and beyond.The scientific and clinical communities make wide use of relevant databases and/or integrate them with existing infrastructures for storage and sharing of collected data according to FAIR[1] principles, thereby encouraging further use of the data.Policymakers, funders, scientific and clinical communities, patient organisations, regulators, and other relevant bodies are informed of the research advances made and the requirements for a widespread implementation of the innovative therapeutic interventions and complementary approaches.Patients and caregivers are constructively engaged with the research, ensuring that their needs are catered for, with the aim of tangibly benefitting from the interventions. Scope:Neurodegenerative diseases are a high burden for patients, caregivers, health systems and society. Given the limitations with current therapeutic solutions, including that they primarily address symptoms rather than underlying causes and can have serious side effects, together with the increasing prevalence of neurodegenerative diseases in an aging population, there is a huge need to develop more innovative, safer and more effective the

Non capisci questo bando?

L'AI di Bandiora te lo spiega in modo semplice: requisiti, importi, scadenze e a chi è rivolto, tutto chiaro.

Registrati e fatti spiegare il bando dall'AI

Area geografica

eu

Tematiche

ricerca_clinicaneurodegenerative_diseasesinnovazione_terapeuticaclinical_trialshorizon_europesalutericerca_biomedica

Requisiti dettagliati

Questo bando è rivolto a - tipologie di impresa in 3 settori ATECO nell'area eu.

Scopri con l'AI se questo bando è adatto alla tua azienda

Analisi automatica di compatibilità, requisiti e matching in tempo reale

Prova gratis 7 giorni

Questo bando fa per la tua azienda?

L'AI di Bandiora analizza la compatibilità con la tua azienda in tempo reale e ti assiste nella compilazione della candidatura, passo dopo passo.

Altri bandi che potrebbero interessarti

Ultimo aggiornamento: 17 aprile 2026